drugset / Trial / NCT02387203
Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the impact of antibiotic therapy on the disease progression and overall survival of patients with Pseudomyxoma Peritonei (PMP).
Timeline
- Start
- 2015-01
- Primary completion
- 2024-12
- Completion
- 2024-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amoxicillin | Other / unclassified | 1000 mg | Oral |
| Subject | Clarithromycin | Small molecule | 500 mg | Oral |
| Subject | Lansoprazole | Other / unclassified | 30 mg | Oral |